[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479199":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":59,"centralContacts":58,"locations":63,"responsibleParty":83,"collaborators":85,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":58,"eligibilityCriteria":95,"healthyVolunteers":91,"sex":96,"minAge":97,"maxAge":58,"enrollmentInfo":98,"targetDuration":58,"studyType":101,"phases":102,"briefSummary":104,"conditions":105,"keywords":58,"overallStatus":65,"whyStopped":58,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"City of Hope Medical Center","OTHER",[8,15,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm I (BWL)","EXPERIMENTAL","Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses.",[13,14],"Device: Bright White Light Therapy","Other: Questionnaire Administration",{"label":16,"type":10,"description":17,"interventionNames":18},"Arm II (OT)","Patients undergo 6 occupational therapist-led sessions over 60 minutes each.",[19,14],"Behavioral: Occupational Therapy",{"label":21,"type":10,"description":22,"interventionNames":23},"Arm III (OT, BWL)","Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses and to complete the occupational therapist-led session over 60 minutes.",[13,19,14],{"label":25,"type":26,"description":27,"interventionNames":28},"Arm IV (Control)","ACTIVE_COMPARATOR","Patients undergo routine treatment and usual follow up care with their medical oncologist.",[29,14],"Other: Best Practice",[31,38,47,54],{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"Best Practice","Undergo routine treatment and usual follow up care",[25],[36,37],"standard of care","standard therapy",{"type":39,"name":40,"description":41,"armGroupLabels":42,"otherNames":43},"DEVICE","Bright White Light Therapy","Undergo bright white therapy",[9,21],[44,45,46],"Bright Light Therapy","Bright White Light","BWL",{"type":48,"name":49,"description":50,"armGroupLabels":51,"otherNames":52},"BEHAVIORAL","Occupational Therapy","Undergo occupational therapy",[16,21],[53],"OT",{"type":6,"name":55,"description":56,"armGroupLabels":57,"otherNames":58},"Questionnaire Administration","Complete questionnaires",[9,16,21,25],null,[60],{"name":61,"affiliation":5,"role":62},"William Dale","PRINCIPAL_INVESTIGATOR",[64],{"facility":5,"status":65,"city":66,"state":67,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":77},"RECRUITING","Duarte","California","91010","United States","US",{"type":72,"coordinates":73},"Point",[74,75],-117.97729,34.13945,{"lat":75,"lon":74},[78,82],{"name":61,"role":79,"phone":80,"phoneExt":58,"email":81},"CONTACT","626-256-4673","wdale@coh.org",{"name":61,"role":62,"phone":58,"phoneExt":58,"email":58},{"type":84,"investigatorFullName":58,"investigatorTitle":58,"investigatorAffiliation":58,"oldNameTitle":58,"oldOrganization":58},"SPONSOR",[86],{"name":87,"class":88},"National Cancer Institute (NCI)","NIH","100479199","light-therapy-and-occupational-therapy-fatigue-management-based-intervention-for-patients-with-genitourinary-cancers-100479199",false,"NCT05519878","Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers","Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers","Inclusion Criteria:\n\n* Aged 18 and over\n* Sufficiently fluent in English\n* On active treatment receiving systemic therapy (e.g., chemotherapy, immunotherapy, hormonal therapy, etc.) or radiotherapy\n* Patients with diagnosis of a genitourinary (GU) cancer (e.g., prostate, kidney, and bladder cancer) who have grade 1 or 2 fatigue based on physician assessment at the time of study entry\n* Clinician assessed prognosis of greater than or equal to six months\n* Willing and independently able to provide consent\n* Receive a pre-screen FACIT-Fatigue score of less than or equal to 30\n\nExclusion Criteria:\n\n* Severe sleep disorders (e.g. narcolepsy)\n* Eye Diseases which limit the ability of light to be processed (e.g. untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or other retinal disorder)\n* Severe psychological impairment (e.g., bipolar disorder or manic episodes)\n* Current employment in night shift work\n* Previous use of light therapy to alleviate fatigue or depressive symptoms\n* Secondary cancer diagnosis within the past 5 years\n* Plans to travel across meridians during treatment\n* Pregnancy\n* Currently recovering from previous eye surgery within the past 6 months that causes eye irritation\n* Sensitivity to light, epilepsy, or a history of seizures","ALL","18 Years",{"count":99,"type":100},224,"ESTIMATED","INTERVENTIONAL",[103],"NA","This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.",[106,107,108,109],"Bladder Carcinoma","Genitourinary System Neoplasm","Kidney Carcinoma","Prostate Carcinoma","2025-12-22",{"date":112,"type":113},"2025-12-24","ACTUAL",{"date":115,"type":113},"2022-11-29",{"date":117,"type":100},"2027-05-25",{"name":5,"class":6},1]